TGFB1 anticorps (AA 279-390)
Aperçu rapide pour TGFB1 anticorps (AA 279-390) (ABIN6780414)
Antigène
Voir toutes TGFB1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 279-390
-
Purification
- Affinity purified
-
Immunogène
-
Recombinant TGFb1 (Ala279-Ser390) expressed in E. coli.
Type of Immunogen: Recombinant protein -
Isotype
- IgG
-
-
-
-
Indications d'application
-
Approved: WB (1:100 - 1:400)
Usage: ICC 5-30 μg/mL, WB 0.5-5 μg/mL, -
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.4, 0.02 % sodium azide, 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C,-80 °C
-
Stockage commentaire
- Store frozen product at or below -20°C. Thawed product may be stored for 2-4 weeks at 4°C. For optimal storage, aliquot to smaller portions and store at -20°C to -70°C. Avoid freeze-thaw cycles.
-
-
- TGFB1 (Transforming Growth Factor, beta 1 (TGFB1))
-
Autre désignation
- TGFB1 / TGF beta 1
-
Sujet
-
Name/Gene ID: TGFB1
Family: TGF beta
Synonyms: TGFB1, CED, DPD1, Diaphyseal dysplasia 1, LAP, Latency-associated peptide, TGF Beta, TGFbeta, TGF-beta 1 protein, TGF-beta-1, TGFB -
ID gène
- 7040
-
Pathways
- EGFR Signaling Pathway, Dopaminergic Neurogenesis, Cellular Response to Molecule of Bacterial Origin, Glycosaminoglycan Metabolic Process, Regulation of Leukocyte Mediated Immunity, Regulation of Muscle Cell Differentiation, Positive Regulation of Immune Effector Process, Cell-Cell Junction Organization, Production of Molecular Mediator of Immune Response, Ribonucleoside Biosynthetic Process, Skeletal Muscle Fiber Development, Regulation of Carbohydrate Metabolic Process, Protein targeting to Nucleus, Autophagy, Cancer Immune Checkpoints
Antigène
-